the anticoagulation after the hybrid surgery of acute aortic syndrome

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000037027

Enrollment

Unknown

Registered

2020-08-26

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-09-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute aortic syndrome

Interventions

Group A:asprin

Group B:asprin + Clopidogrel

Group C:warfarin

Group D:asprin+warfarin

Group E:Ticagrelor

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with acute aortic syndrome requiring hybrid surgery.

Exclusion criteria

Exclusion criteria: 1. Patients are unable or unwilling to receive anticoagulant therapy due to their own reasons; 2. The patient has primary hemorrhagic disease or thrombotic disease; 3. Patients who underwent endovascular treatment or thoracotomy for total aortic arch replacement; 4. Patients who are not sensitive to anticoagulant drugs; 5. Patients who cannot be followed up;

Design outcomes

Primary

Measure	Time frame
expand rate of the false lumen;Thrombus rate of artificial blood vessel;	—

Countries

China

Contacts

Public ContactChenjun Han

Shanghai Tenth Peoples' Hospital

hanson1163@163.com+86 021-66302295

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026